"The purpose of the conference was to allow vascular physicians from around the world to learn about breaking news vein removal technology and participate in discussions with their peers," Kingsley says.
Birmingham, AL (PRWEB) January 5, 2010
Veinwave™ was selected as one of five industry leaders to present its revolutionary vein removal technology at the Inaugural Phlebology Meeting held at The Peaks Resort & Golden Door Spa in Telluride, Colo., in December 2009. The companies were hand-selected on the basis of safety, efficacy, and proven results.
The meeting was the brain-child of John R. Kingsley, M.D. and James H. Isobe, M.D, founders of the Alabama Phlebology Training Institute. Dr. Kingsley is president and CEO of the Alabama and Atlanta Vascular & Vein Centers located in Birmingham, AL. and Atlanta, GA. d States. The conference was designed for world-renowned vascular surgeons to learn about the latest vein treatment technology and techniques.
Dr. John Kingsley is doubly Board Certified by the American Board of Surgery in general surgery and vascular surgery. Board Certification in vascular surgery in the U.S. is considered a special credential and only some 3,000 surgeons have qualified and successfully completed the requirements and the examinations to date. He is also a Board Certified phlebologist by the American College of Phebology and one of the original physicians in the U.S. to develop and practice modern vein treatment methods. Dr. Kingsley is one of the few certified Veinwave Trainers in the US.
Dr. Kingsley has performed more than 5,000 endovenous ablation operations and he and his colleagues have performed more than 8,000 such procedures. His Alabama Phlebology Training Institute is one of the premier training centers in the U.S. where other physicians and support staff learn the modern vein treatment methods.
In 2009, Dr. Kingsley was selected President of the Alabama Vascular Society, an honor he will fulfill until 2011. He is past President of the American Society of Outpatient Surgeons, and Chairman of the Surgery Dept. of Carraway Medical Center in Birmingham. He is a selected Fellow of the American Society of Vascular Surgery and the Southern Association of Vascular Surgeons. He is the primary U.S. consultant for the Tokyo Vein Clinic, and in 2007 was selected to the Australasian College of Phlebology as an Emeritus Fellow. He achieved the rank of Commander in the U.S. Navy, and was awarded the prestigious honorable discharge upon his completion of service. He has been chosen one of the top surgeons in the U.S. for the past 7 years by the Consumers Research Council of America of Washington, D.C. He is the author of over 70 publications and presentations regarding his expertise in vascular and vein surgery.
The Veinwave is the world's most advanced treatment for effective removal of unwanted spider veins and telangiectasia. Developed by Dr. Brian Newman, an internationally-acclaimed vascular surgeon based in the United Kingdom, Veinwave has been used for nearly a decade by over 1,000 physicians in Europe. Veinwave recently received 510k clearance from the FDA to market in the USA. An independent six-year study from Georges Pompidou Hospital documents the safety and effectiveness of this proprietary system with no side effects.
Veinwave uses a revolutionary process called Unipolar Thermo-Coagulation (UTC), wherein a unique localized energy is applied to the skin on top of the affected area, causing the vein walls to collapse and the vein to disappear instantly. Vein removal with the Veinwave provides safe, quick, and dramatic reduction of unwanted veins on any skin type, including ethnic and dark-skinned individuals. The technology significantly minimizes pain and the risks of bruising, burning, scaring and pigmentation changes that are associated with alternative treatments such as lasers and other light based systems. As a result, Veinwave has become the treatment of choice for practitioners and patients alike, providing a relatively painless walk-in/walk-out procedure with no bandages nor post-procedure care. Patients can resume regular activities and normal sun exposure immediately following treatment.
The Veinwave system was recently purchased by the CardioVascular Institute (CVI) at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. CVI is the first Boston health care organization to purchase the revolutionary Veinwave system.
For more information, visit http://www.VeinwaveUSA.com or call (205) 427-9323.